Cargando…
Randomised Double-blind Placebo-Controlled Multicentre Trial for the Effects of Yokukansan in Smokers with Depressive Tendencies
Autores principales: | Komiyama, Maki, Ozaki, Yuka, Wada, Hiromichi, Yamakage, Hajime, Satoh-Asahara, Noriko, Yasoda, Akihiro, Sunagawa, Yoichi, Morimoto, Tatsuya, Takahashi, Yuko, Hasegawa, Koji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radcliffe Cardiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316361/ https://www.ncbi.nlm.nih.gov/pubmed/37405335 http://dx.doi.org/10.15420/ecr.2023.18.PO13 |
Ejemplares similares
-
Randomized double-blind placebo-controlled multicenter trial for the effects of a polyherbal remedy, Yokukansan (YiganSan), in smokers with depressive tendencies
por: Komiyama, Maki, et al.
Publicado: (2022) -
Psychological Effects of Aromatherapy on Smokers With Depressive Tendencies During Smoking Cessation Treatment: Protocol for a Pre-Post Single-Arm Clinical Trial
por: Hata, Akiko, et al.
Publicado: (2022) -
HDL Mimetics Enhances Mitochondrial Function via Stimulation of PGC1-α
por: Zhang, Hang, et al.
Publicado: (2023) -
Evolocumab is initiated in Central and Eastern Europe at Much Higher LDL-C Levels than Recommended in Guidelines: Results from the Observational HEYMANS Study
por: Blaha, V, et al.
Publicado: (2023) -
Use of Heart Failure-Exacerbating Medications among Heart Failure Patients in a Tertiary Referral Centre in Malaysia
por: Wong, Yii Ching
Publicado: (2023)